Vidal, Ana G. Jop
Francis, Meg
Chitanvis, Maneesha
Takeshita, Kenichi
Frame, Ithiel J.
Sharma, Poonam
Vidal, Patricio
Lanata, Claudio F.
Grijalva, Carlos
Daley, William
Vidal, Jorge E.
Funding for this research was provided by:
National Institutes of Health (5R21AI144571-03)
International Society of Pneumonia and Pneumococcal Diseases (2024 Robert Austrian Research Award)
Article History
Received: 27 September 2024
Accepted: 9 January 2025
First Online: 5 March 2025
Declarations
:
: The research project “Mechanistic Studies of Broadly Reactive Antibodies for the Treatment, Diagnosis, and Prevention of Pneumococcal Infection” has been reviewed by the Institutional Review Board (IRB) of the University of Mississippi Medical Center (Federalwide Assurance FWA#00003630) and has been determined to be exempt from formal review. The IRB concluded that the project meets the criteria for exemption as outlined in the U. S. Department of Health and Human Services Regulations for the Protection of Human Subjects, 45 CFR 46.102(l) because this project does not research involving human subjects. As such, no additional ethical review was required. All experiments involving animals were performed with prior approval of and in accordance with protocol 1584 which was reviewed and approved by the UMMC Animal Care Committee. UMMC laboratory animal facilities have been fully accredited by the American Association for Accreditation of Laboratory Animal Care. Procedures were performed according to the institutional policies, Animal Welfare Act, NIH guidelines, and American Veterinary Medical Association guidelines on euthanasia.
: N/A.
: N/A.
: The authors declare no competing interests.